Skip to main content
Figure 3 | Implementation Science

Figure 3

From: A knowledge translation tool improved osteoporosis disease management in primary care: an interrupted time series analysis

Figure 3

Percentage of patients for whom any osteoporosis medication was prescribed (bisphosphonates [alendronate, etidronate, risedronate, or zoledronic acid], selective estrogen receptor modulators [ e.g. , raloxifene], nasal calcitonin, parathyroid hormone, or hormone replacement therapy): represented for each site as well as for sites overall (July 2009 to November 2010). The 52 data points represent 26 two-week segments before and 26 two-week segments after the introduction of the intervention (vertical rule).

Back to article page

Implementation Science

ISSN: 1748-5908